In AML, U2AF1MUT mediates the inclusion of IRAK4 exon 4 and, therefore, the expression of the IRAK4 long isoform (IRAK4-L), which is frequently expressed in AML patients with poor outcome [59]. This evidence concerns the gene IRAK4 and acute myeloid leukemia.